Mechanisms of Hormonal Prevention of Breast Cancer
- 1 December 2001
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 952 (1) , 23-35
- https://doi.org/10.1111/j.1749-6632.2001.tb02725.x
Abstract
Reproductive history is a consistent risk factor for human breast cancer. Epidemiological studies have repeatedly demonstrated that early age of first pregnancy is a strong protective factor against breast cancer and provides a physiologically operative model to achieve a practical mode of prevention. In rodents, the effects of full-term pregnancy can be mimicked by a three-week exposure to low doses of estrogen and progesterone. Neither hormone alone is sufficient to induce protection. The cellular and molecular mechanisms that underlie hormone-induced refractoriness are largely unresolved. Our recent studies have demonstrated that an early cellular response that is altered in hormone-treated mammary cells is the initial proliferative burst induced by the chemical carcinogen methylnitrosourea. The decrease in proliferation is also accompanied by a decrease in the ability of estrogen receptor-positive cells to proliferate. RNA expression of several mammary cell-cycle-related genes is not altered in hormone-treated mice; however, immunohistochemical assays demonstrate that the protein level and nuclear compartmentalization of the p53 tumor suppressor gene are markedly upregulated as a consequence of hormone treatment. These results support the hypothesis that hormone stimulation, at a critical period in mammary development, results in cells with persistent changes in the intracellular regulatory loops governing proliferation and response to DNA damage. A corollary to this hypothesis is that the genes affected by estrogen and progesterone are independent of alveolar differentiation-specific genes. Suppressive subtractive hybridization-PCR methods have identified several genes that are differentially expressed as a consequence of prior estrogen and progesterone treatment. Future experiments are aimed at determining the mechanisms of hormone-induced upregulation of p53 protein expression as part of the overall goal of identifying and functionally characterizing the genes responsible for the refractory phenotype.Keywords
This publication has 17 references indexed in Scilit:
- Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylationGenes & Development, 1999
- Chemical Carcinogen-Induced Tumorigenesis in Parous, Involuted Mouse Mammary GlandsJNCI Journal of the National Cancer Institute, 1999
- Protective effects of pregnancy and lactation against N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis ratsCarcinogenesis: Integrative Cancer Research, 1999
- Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?Carcinogenesis: Integrative Cancer Research, 1995
- Dual Retinoblastoma-binding Proteins with Properties Related to a Negative Regulator of Ras in YeastPublished by Elsevier ,1995
- Breast CancerNew England Journal of Medicine, 1992
- Toward the Primary Prevention of CancerScience, 1991
- The epidemiology of breast cancerCA: A Cancer Journal for Clinicians, 1991
- Human Chorionic Gonadotropin and Rat Mammary Cancer PreventionJNCI Journal of the National Cancer Institute, 1990
- Relationship between previous reproductive history and chemically induced mammary cancer in ratsInternational Journal of Cancer, 1969